Get the Stockscreener App
2.195
0.40%
-0.005
Cronos Group Inc stock is traded at $2.195, with a volume of 1.40M.
It is down -0.40% in the last 24 hours and down -2.18% over the past month.
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
See More
Previous Close:
$2.20
Open:
$2.19
24h Volume:
1.40M
Relative Volume:
1.56
Market Cap:
$844.84M
Revenue:
$87.89M
Net Income/Loss:
$-73.96M
P/E Ratio:
-5.7763
EPS:
-0.38
Net Cash Flow:
$-46.26M
1W Performance:
+0.05%
1M Performance:
-2.18%
6M Performance:
-18.24%
1Y Performance:
+17.81%
1-Day Range:
$2.12
$2.2255
1-Week Range:
$2.09
$2.26
52-Week Range:
$1.83
$3.14
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
(416) 504-0004
Address
4491 CONCESSION RD 12, STAYNER, ON
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
| Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
| Nov-18-21 | Resumed | BofA Securities | Underperform |
| Apr-28-21 | Resumed | BofA Securities | Underperform |
| Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
| Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
| Mar-03-20 | Downgrade | Stifel | Buy → Hold |
| Oct-18-19 | Upgrade | Stifel | Hold → Buy |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Aug-13-19 | Initiated | Piper Jaffray | Overweight |
| Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
| Apr-17-19 | Initiated | BofA/Merrill | Underperform |
| Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-25-19 | Initiated | Jefferies | Underperform |
| Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
Cronos Group (CRON) Set to Announce Earnings on Tuesday - MarketBeat
Altria’s investment in Cronos is costing it millions - Green Market Report
Cronos Group Inc. stock falls Wednesday, underperforms market - MarketWatch
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024 - GlobeNewswire
Cronos Group Inc. stock rises Monday, outperforms market - MarketWatch
Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch
Cronos Group Inc. stock falls Thursday, underperforms market - MarketWatch
Spotlight On TSX Penny Stocks For October 2024 - Simply Wall St
Cronos Group (NASDAQ:CRON) Trading Up 6.1%Time to Buy? - MarketBeat
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Canadian cannabis company Cronos Group sells Peace Naturals campus for about $17M - MSN
Cronos Group Inc. stock remains steady Wednesday, underperforms market - MarketWatch
Cronos Group (TSE:CRON) Stock Price Down 1.6%What's Next? - MarketBeat
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Spinach® Is the Number One Cannabis Brand in Canada - GlobeNewswire
Cronos Group Inc (CRON) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Cronos Group Inc (CRON) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
3 Cannabis Stocks to Monitor as the Election Approaches - Schaeffers Research
Cronos Group Inc. stock remains steady Friday, underperforms market - MarketWatch
Cronos Group Inc. stock rises Thursday, outperforms market - MarketWatch
Cronos Group (NASDAQ:CRON) Trading 3.7% Higher - MarketBeat
Mackenzie Financial Corp Acquires Shares of 1,387,906 Cronos Group Inc. (NASDAQ:CRON) - MarketBeat
Top 10 Cannabis Stocks in a Growing Market (October 2024) - Securities.io
Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group (CRON) Investors with $250K+ Losses to Contact its Attorneys: May 11 Deadline Looming - AccessWire
Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch
Cronos Group Inc. (CRON): A Bull Case Theory - Insider Monkey
Cronos Group Inc. (CRON): Analysts Are Bullish On This Best Debt-Free Penny Stock Now - Insider Monkey
CBD Market Strategies and Insight Driven Transformation 2022-2030 | The Cronos Group, Kiehl’s LLC., Cannuka LLC, Elixinol Global Limited, Isodiol International Inc. – Cauverynews - Cauverynews
CIBC Asset Management Inc Invests $87,000 in Cronos Group Inc. (NASDAQ:CRON) - Defense World
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group (CRON) Investors with $250K+ Losses to Contact its Attorneys: Company Admits Improper Revenue Recognition and Important Investor Deadlines Approaching - AccessWire
Cronos Group Inc. stock outperforms market despite losses on the day - MarketWatch
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit? - Benzinga
Panel finds Cronos Group tried to “reverse hijack” domain name - StratCann
Cronos Group Inc. stock falls Tuesday, still outperforms market - MarketWatch
Cronos Group (NASDAQ:CRON) Shares Gap Up to $2.26 - MarketBeat
Cannabis company tries reverse domain name hijacking - Domain Name Wire
Cronos Remains Far From Critical Mass to Achieve Profitability; Cash Hoard Is Most of Its Value - Morningstar
Cronos Group Inc Stock (CRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):